**7. References**

622 Amyotrophic Lateral Sclerosis

Fig. 6. Effects of Riluzole on the macro EMG and MUNE parameters with the time, in patients intaking (filled circle) or not (empty circle) the drug (modified from Sartucci et al., 2011).


How to Assess Disease's Severity and Monitor Patients with

Neuroreport 11:3493-3497.

Disord 1 Suppl 2:S41-44.

Muscle Nerve 23:193-197.

Muscle Nerve 19:1069-1083.

Neurosci 117:1229-1236.

Neurol (Paris) 162 Spec No 2:4S34-34S42.

Year Follow Up. Int J Neurosci 121(5):257-66.

Stålberg E (1983), Macro EMG. Muscle Nerve 6:619-630.

Stålberg E (1983), Macro EMG. Muscle Nerve 6:619-630.

Scler Other Motor Neuron Disord 2:171-172.

Neurosurg Psychiatry 45:870-878.

190:21-27.

234.

43:475-482.

Amyotrophic Lateral Sclerosis: Lessons From Neurophysiology 625

Nakamizo T, Urushitani M, Inoue R, Shinohara A, Sawada H, Honda K, Kihara T, Akaike A,

Olney RK, Lomen-Hoerth C (2000), Motor unit number estimation (MUNE): how may it

Olney RK, Yuen EC, Engstrom JW (2000), Statistical motor unit number estimation:

Pohl C, Block W, Traber F, Schmidt S, Pels H, Grothe C, Schild HH, Klockgether T (2001),

Pouget J (2006), [Electroneuromyographic criteria of amyotrophic lateral sclerosis]. Rev

Sanders DB, Stålberg EV (1996), AAEM minimonograph #25: single-fiber electromyography.

Sartucci F, Maritato P, Moscato G, Orlandi G, Calabrese R, Domenici GL, Murri L (2007),

Sartucci F, Moscato G, Rossi C, Caleo M, Bocci T, Murri L, Giannini F, Rossi A (2011), Macro-

Schwartz MS, Stålberg E, Schiller HH, Thiele B (1976), The reinnervated motor unit in man. A single fibre EMG multielectrode investigation. J Neurol Sci 27:303-312. Shefner JM, Cudkowicz ME, Brown RH, Jr. (2002), Comparison of incremental with multipoint MUNE methods in transgenic ALS mice. Muscle Nerve 25:39-42. Shefner JM, Cudkowicz ME, Zhang H, Schoenfeld D, Jillapalli D (2007), Revised statistical

Stålberg E (1980), Macro EMG, a new recording technique. J Neurol Neurosurg Psychiatry

Stålberg E, Fawcett PR (1982), Macro EMG in healthy subjects of different ages. J Neurol

Stålberg E, Schwartz MS, Thiele B, Schiller HH (1976), The normal motor unit in man. A single fibre EMG multielectrode investigation. J Neurol Sci 27:291-301. Strong MJ, Brown WF, Hudson AJ, Snow R (1988), Motor unit estimates in the bicepsbrachialis in amyotrophic lateral sclerosis. Muscle Nerve 11:415-422. Swash M (2001), ALS and motor neuron disorders today and tomorrow. Amyotroph Lateral

Shimohama S (2000), Protection of cultured spinal motor neurons by estradiol.

contribute to the diagnosis of ALS? Amyotroph Lateral Scler Other Motor Neuron

reproducibility and sources of error in patients with amyotrophic lateral sclerosis.

Proton magnetic resonance spectroscopy and transcranial magnetic stimulation for the detection of upper motor neuron degeneration in ALS patients. J Neurol Sci

Motor unit number estimation (mune) as a quantitative measure of disease progression and motor unit reorganization in amyotrophic lateral sclerosis. Int J

EMG and MUNE Changes in Patients with Amyotrophic Lateral Sclerosis: One-

motor unit number estimation in the Celecoxib/ALS trial. Muscle Nerve 35:228-


Finsterer J, Fuglsang-Frederiksen A (2001), Concentric-needle versus macro EMG. II. Detection of neuromuscular disorders. Clin Neurophysiol 112:853-860. Gan R, Jabre JF (1992), The spectrum of concentric macro EMG correlations. Part II. Patients

Gooch CL, Shefner JM (2004), ALS surrogate markers. MUNE. Amyotroph Lateral Scler

Guiloff RJ, Modarres-Sadeghi H, Stålberg E, Rogers H (1988), Short-term stability of single

Hegedus J, Putman CT, Gordon T (2009), Progressive motor unit loss in the G93A mouse

Henderson RD, Ridall PG, Hutchinson NM, Pettitt AN, McCombe PA (2007), Bayesian

Hong YH, Sung JJ, Park KS, Kwon O, Min JH, Lee KW (2007), Statistical MUNE: a

Juergens SM, Kurland LT, Okazaki H, Mulder DW (1980), ALS in Rochester, Minnesota,

Kruman, II, Pedersen WA, Springer JE, Mattson MP (1999), ALS-linked Cu/Zn-SOD

Kwon O, Lee KW (2004), Reproducibility of statistical motor unit number estimates in

Leigh PN, Abrahams S, Al-Chalabi A, Ampong MA, Goldstein LH, Johnson J, Lyall R,

neurone disease. J Neurol Neurosurg Psychiatry 74 Suppl 4:iv32-iv47. Liu XX, Zhang J, Zheng JY, Zhang S, Xu YS, Kang DX, Fan DS (2009), Stratifying disease

patients with amyotrophic lateral sclerosis. Muscle Nerve 39:304-309. McComas AJ (1995), Motor unit estimation: anxieties and achievements. Muscle Nerve

McComas AJ, Fawcett PR, Campbell MJ, Sica RE (1971), Electrophysiological estimation of

Miller RG, Mitchell JD, Lyon M, Moore DH (2003), Riluzole for amyotrophic lateral sclerosis

Miller RG, Mitchell JD, Lyon M, Moore DH (2007), Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev CD001447.

motor unit recordings in motor neuron disease: a macro EMG study. J Neurol

model of amyotrophic lateral sclerosis is unaffected by gender. Muscle Nerve

comparison of two methods of setting recording windows in healthy subjects and

mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis. Exp

amyotrophic lateral sclerosis: comparisons between size- and number-weighted

Moxham J, Mustfa N, Rio A, Shaw C, Willey E (2003), The management of motor

stages with different progression rates determined by electrophysiological tests in

the number of motor units within a human muscle. J Neurol Neurosurg Psychiatry

(ALS)/motor neuron disease (MND). Amyotroph Lateral Scler Other Motor

with diseases of muscle and nerve. Muscle Nerve 15:1085-1088.

Other Motor Neuron Disord 5 Suppl 1:104-107.

statistical MUNE method. Muscle Nerve 36:206-213.

Jabre JF (1991), Concentric macro electromyography. Muscle Nerve 14:820-825.

ALS patients. Clin Neurophysiol 118:2605-2611.

Neurosurg Psychiatry 51:671-676.

1925-1977. Neurology 30:463-470.

modifications. Muscle Nerve 29:211-217.

Neurol 160:28-39.

18:369-379.

34:121-131.

Neuron Disord 4:191-206.

39:318-327.


**28** 

Arun Aggarwal *University of Sydney* 

*Australia* 

**Protection of Motor Neurons in** 

**Pre-Symptomatic Individuals Carrying SOD 1** 

Amyotrophic lateral sclerosis (ALS) is a progressive degenerative disease of motor neurones. There is a family history in approximately 10% percent of cases. Only 20% of such families have point mutations in the Cu, Zn superoxide dimutase 1 (SOD1) gene. Pre-symptomatic loss of motor neurons has been identified prior to the onset of symptoms in SOD1 mice. This loss was biphasic with initial loss in the pre-symptomatic phase followed by a period of

In order to determine the time course of motor neurone loss prior to symptomatic onset of disease, a longitudinal study of at-risk asymptomatic individuals (i.e. SOD1 mutation carriers with no neurological symptoms or signs as determined by a neurologist) was

There was no detectable difference in the number of motor units in SOD1 mutation carriers compared to their SOD1 negative family controls. (Aggarwal & Nicholson, 2001). This may indicate that mutation carriers have undetectable loss of motor neurones until rapid and widespread cell death of motor neurones occurs, coinciding with the onset of symptomatic features. This implies that the disease is not the end result of the slow attrition of motor

The longitudinal study was extended on 20 asymptomatic carriers of the Cu, Zn superoxide dimutase 1 (SOD1) point mutation. In 2 of the 20 mutation carriers, there was a sudden reduction in MUNE, several months prior to the onset of weakness. (Aggarwal & Nicholson 2002), which also occurred in another 3 mutation carriers over the course of the study.

This suggests that gradual pre-clinical loss of motor neurones does not occur in asymptomatic SOD1 mutation carriers and supports the observation that sudden, catastrophic loss of motor neurones occurs immediately prior to the onset of symptoms and the development of the disease, rather than a gradual attrition of motor neurones over time. These results suggest that there may be a biological trigger initiating rapid cell loss, just prior to the onset of symptoms. This observation is an important contribution to the current

stabilisation and then gradual loss at time of weakness to death. (Kong & Xu, 1998).

**1. Introduction** 

performed.

neurones. (Aggarwal, 2009).

understanding of the pathogenesis of MND.

(Aggarwal, 2009).

**Mutations: Results of Motor Unit Number** 

**Estimation (MUNE) Electrophysiology** 

